Real-world dose reduction of standard and modified FOLFIRINOX in metastatic pancreatic cancer: a systematic review, evidence-mapping, and meta-analysis.

Kwangrok Jung,Suhyun Choi,Hyunjoo Song,Kyuhan Kwak, Soyeon Anh,Jae Hyup Jung,Bomi Kim,Jinwoo Ahn,Jaihwan Kim,Jin-Hyeok Hwang,Jong-Chan Lee

Therapeutic advances in medical oncology（2023）

引用 0|浏览10

暂无评分

摘要

RDI-map.com enables multifactorial evidence-mapping for practical FOLFIRINOX dose reduction. The pattern of dose modification was not consistent across studies, and there was a significant gap between the 'planned' and 'actual' doses. Modified FOLFIRINOX showed similar efficacy to the standard regimen with reduced incidence of febrile neutropenia.

查看译文

关键词

dose modification, evidence-mapping, metastatic pancreatic cancer, modified FOLFIRINOX, standard FOLFIRINOX

AI 理解论文

溯源树

样例

生成溯源树，研究论文发展脉络

Chat Paper

正在生成论文摘要